Antibody Purification in Bioprocessing

On this page:

Increase yield and efficiency in antibody purification

Rising upstream titers and expanding antibody format complexity from conventional monoclonal antibodies (mAbs) and mAb biosimilars to bispecifics (BsAbs), antibody fragments (Fabs), and Fc-fusion proteins place mounting pressure on downstream purification processes. Additional chromatography steps can reduce product yield, increase cost, and extend time-to-clinic or commercial launch. Affinity chromatography combines high selectivity with broad impurity clearance in a single capture operation. It reduces the number of downstream steps required and helps maximize yield from the outset of the purification train.

Impact of process steps on yield and timelines

As the number of unit operations increases, cumulative product losses and additional process optimization can affect recovery and extend development times.

Purification demands for next-generation formats

Bispecific antibodies, antibody fragments, and Fc-fusion proteins can present purification challenges. Many formats have modified or absent Fc regions. These modalities may require affinity solutions with different subdomain-specific selectivity.


Affinity capture for mAb purification

The affinity capture step is the primary operation in a downstream purification train. In a single pass, it can reduce the bulk of process-related impurities, including host cell proteins (HCP), cell debris, and DNA. Protein A chromatography resins remain a widely adopted choice for mAb capture. Thermo Fisher Scientific offers an extensive affinity capture portfolio: the Thermo Scientific MabCaptureC Affinity Matrix for Protein A-based mAb capture, and CaptureSelect affinity resins for formats requiring other subdomain-specific selectivity.
 


Protein A chromatography for mAb capture

The Thermo Scientific MabCaptureC Affinity Matrix is a high-performance Protein A resin designed for process-scale monoclonal antibody and mAb biosimilar purification. Designed to offer cost-savings, with a dynamic binding capacity (DBC) greater than 50 g/L at a residence time of 4.8 minutes, it can support cost-effective, high-throughput capture operations.


 

CaptureSelect affinity resins for bispecifics, antibody fragments, and Fc-fusion proteins

CaptureSelect affinity resins are based on single-domain VHH antibody fragment-derived ligands that bind antibody subdomains with high specificity. Their compact structure allows access to epitopes that larger Protein A ligands cannot reach, enabling subdomain-selective capture of complex formats.

 

CaptureSelect subdomain-specific resins, including CaptureSelect CH1-XL, CaptureSelect KappaXP, CaptureSelect LambdaXP, CaptureSelect FcXP, and POROS CaptureSelect FcXP, are designed to support the purification of bispecific antibodies, antibody fragments, F(ab')2, Fc-fusion proteins, and advanced format biosimilars. CaptureSelect CH1-XL targets the CH1 domain and does not co-purify free light chains, enabling platform purification of human IgG and antibody fragments with elution at a mild pH 4–4.5.


Polishing solutions for antibody purification

Following affinity capture, additional antibody purification techniques are used to reduce residual process- and product-related impurities before the drug substance advances to formulation. Thermo Scientific POROS chromatography resins are designed for intermediate and final polishing in antibody purification workflows. Their 50 µm bead size and poly(styrene-divinylbenzene) backbone support high-capacity, high-resolution, and flow rate-independent performance. Available chemistries include ion exchange chromatography (IEX), hydrophobic interaction (HIC), and mixed-mode (MMC) to address a broad range of polishing requirements across different antibody formats and process conditions.

 


IEX chromatography for mAb polishing

POROS cation exchange resins, such as POROS XS and POROS 50 HS, support mAb polishing in bind/elute or flow-through mode. These resins have wide pH compatibility and high binding capacity across varied process conditions.

 

POROS anion exchange resins, including POROS XQ, POROS 50 HQ, POROS 50 PI, and POROS 50 D, are designed for impurity reduction and can be operated in flow-through mode to simplify process development.



Hydrophobic interaction and mixed-mode resin

POROS HIC resins, Ethyl, Benzyl, and Benzyl Ultra, are designed for aggregate reduction and product-related impurity clearance in the purification of antibodies. Mixed-mode resin, such as POROS Caprylate Mixed-Mode Cation Exchange Chromatography Resin, is a flow-through polishing option designed for improved process economics and broader operating space, supporting efficient aggregate clearance with minimal product loss.


High-throughput screening and process development

RoboColumn™ prepacked columns, GoPure columns, MiniChrom™ columns,  and 96-well screening plates support automated, parallel resin screening and process development at bench scale. These formats allow process development scientists to evaluate resin candidates and optimize conditions before committing to process-scale operations.

 


Support scalable manufacturing and supply reliability

Selecting a single supplier for affinity capture and polishing resins can reduce supply chain complexity and streamline regulatory documentation across the purification workflow. CaptureSelect affinity resins are manufactured at ISO-certified facilities in Naarden, Netherlands, with second-site sourcing in Vilnius, Lithuania. POROS chromatography resins are produced at ISO-certified facilities in Bedford and Chelmsford, Massachusetts. Traceability of raw materials and second-site manufacturing help support continuity in clinical and commercial antibody production programs.
 


Not sure which resins are right for you?


Selecting the right resin depends on your molecule type, process stage, and purification goals. Compare chemistries, binding capacities, and scalability data in one place.
 

Frequently asked questions

The widely adopted mAb purification platform typically consists of Protein A affinity capture followed by two polishing steps, commonly cation exchange chromatography in bind/elute mode and anion exchange chromatography in flow-through mode. Thermo Fisher Scientific offers chromatography resins designed to address each stage of this workflow from initial capture through final polish.

CaptureSelect resins are well-suited when the antibody format lacks a conventional Fc region, such as bispecific antibodies, antibody fragments, and Fc-fusion proteins, or when Protein A does not yield the desired purity or requires harsh elution conditions. CaptureSelect ligands are designed to elute under mild pH conditions, which helps protect pH-sensitive modalities and may reduce the risk of aggregation during the capture step.

Polishing resin selection depends on the charge properties of the target molecule, the type and level of impurities present, and the desired mode of operation: bind/elute or flow-through. The Bioprocess Resin Selection Guide can help identify appropriate resin candidates based on process parameters. Thermo Fisher Scientific's Application Scientists are available to support process-specific recommendations for antibody purification workflows.

CaptureSelect affinity resins and POROS chromatography resins are manufactured under ISO 13485 and ISO 9001 certification and are designed for use in clinical and commercial production. Regulatory support documentation, including master cell bank data, working cell bank data, toxicology study data, and product-specific leakage ELISAs, is available to support regulatory filings for both clinical-phase and commercial programs.

Chromatography resources


Access resources that cover chromatography performance, purification strategies, and method development. These resources empower scientists to select and apply chromatography resins from research to cGMP manufacturing.

Ready to increase antibody purification process efficiency?


For research and development use only in support of FDA-regulated end uses. Not for diagnostic use or direct administration to humans or animals.